Cargando…
Monitoring Apoptosis of Breast Cancer Xenograft After Paclitaxel Treatment With (99m)Tc-Labeled Duramycin SPECT/CT
Our goal was to validate the feasibility of (99m)Tc-duramycin as a potential apoptosis probe for monitoring tumor response to paclitaxel in breast cancer xenografts. The binding of (99m)Tc-duramycin to phosphatidylethanolamine was validated in vitro using paclitaxel-treated human breast carcinoma MD...
Autores principales: | Luo, Rui, Niu, Lei, Qiu, Fan, Fang, Wei, Fu, Tong, Zhao, Ming, Zhang, Ying-Jian, Hua, Zi-Chun, Li, Xiao-Feng, Wang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469599/ https://www.ncbi.nlm.nih.gov/pubmed/27030401 http://dx.doi.org/10.1177/1536012115624918 |
Ejemplares similares
-
Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis
por: Elvas, Filipe, et al.
Publicado: (2015) -
First-in-human study of a novel cell death tracer [(99m)Tc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers
por: Metelerkamp Cappenberg, Taco, et al.
Publicado: (2023) -
Optimization of SPECT/CT imaging protocols for quantitative and qualitative (99m)Tc SPECT
por: Kupitz, Dennis, et al.
Publicado: (2021) -
SPECT/CT imaging of chemotherapy-induced tumor apoptosis using (99m)Tc-labeled dendrimer-entrapped gold nanoparticles
por: Xing, Yan, et al.
Publicado: (2018) -
Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
por: Liepe, Knut, et al.
Publicado: (2022)